Humoral rejection

Complement component 4

Complement
Complement component 4 is a protein involved in the complement system. It is cleaved into proteins 4a and 4b. C4a is an anaphylatoxin. C4b forms part of C3-convertase, in conjunction with 2a: C4b can bind CR1. C4d is the final proteolytic remnant of deposited C4b on endothelium, remains covalently attached to endothelium for little more than a week and easily detectable by antibody staining. C4d is the most clinically used marker for humoral rejection. It is a degradation product of the activated complement factor C4b. C4d is typically initiated by binding of antibodies to specific target molecules...

Humoral rejection - List of case studies

List of Diseases and Conditions

EBV infection Acute coronary syndrome Acute humoral rejection Acute infectious mononucleosis Acute leukemia Acute ...

End Stage Renal Disease

using C5 inhibitor eculizumab in the prevention of acute humoral rejection in highly sensitized patients was presented by Dr Stegall (Mayo ...

ABO-incompatible (ABOI) renal transplantation

for use in the United States. However, it seems that humoral rejection seems to correlate more closely with pre-transplant antibody titer ...

JustAnswer.com